Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina. Nguyen VH, Vizzotti C, Uruena A, Giglio N, et al. Vaccine 2020;38:3682-3689.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Nguyen VH, Vizzotti C, Uruena A, Giglio N, et al. Cost-effectiveness of introducing an MF59-adjuvanted trivalent influenza vaccine for older adults in Argentina. Vaccine 2020;38:3682-3689.
PMID: 32249017